![David Keane](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Keane
Corporate Officer/Principal presso The United Mitochondrial Disease Foundation
Profilo
David Keane currently works at The United Mitochondrial Disease Foundation, as Member from 2004.
Mr. Keane also formerly worked at MEDomics LLC, as Director-East Coast Marketing, Transgenomic, Inc., as Principal, and Blueprint Genetics, Inc., as Principal.
Mr. Keane received his undergraduate degree from Wake Forest University.
Posizioni attive di David Keane
Società | Posizione | Inizio |
---|---|---|
The United Mitochondrial Disease Foundation | Corporate Officer/Principal | 13/04/2011 |
Precedenti posizioni note di David Keane
Società | Posizione | Fine |
---|---|---|
Transgenomic, Inc.
![]() Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Corporate Officer/Principal | - |
Blueprint Genetics, Inc.
![]() Blueprint Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Athena Diagnostics, Inc. provides clinical diagnostics testing laboratory services. The firm focuses on neurology, endocrinology, hearing loss and nephrology. It offers tests for Alzheimer's disease, muscular dystrophy and other neuromuscular and developmental disorders. The company was founded in 1988 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | - |
MEDomics LLC
![]() MEDomics LLC Miscellaneous Commercial ServicesCommercial Services MEDomics LLC provides diagnostic testing services. It offers treatments, diets, supplements and medication for Mitochondrial disease, intellectual deficiency, epilepsy, and autism. The company was founded by Steve S. Sommer on July 14, 2008 and is headquartered in Azusa, CA. | Vendite & Marketing | - |
Formazione di David Keane
Wake Forest University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
MEDomics LLC
![]() MEDomics LLC Miscellaneous Commercial ServicesCommercial Services MEDomics LLC provides diagnostic testing services. It offers treatments, diets, supplements and medication for Mitochondrial disease, intellectual deficiency, epilepsy, and autism. The company was founded by Steve S. Sommer on July 14, 2008 and is headquartered in Azusa, CA. | Commercial Services |
Transgenomic, Inc.
![]() Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Health Technology |
Blueprint Genetics, Inc.
![]() Blueprint Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Athena Diagnostics, Inc. provides clinical diagnostics testing laboratory services. The firm focuses on neurology, endocrinology, hearing loss and nephrology. It offers tests for Alzheimer's disease, muscular dystrophy and other neuromuscular and developmental disorders. The company was founded in 1988 and is headquartered in Marlborough, MA. | Commercial Services |
The United Mitochondrial Disease Foundation |
- Borsa valori
- Insiders
- David Keane